nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—Alkylating Activity—Melphalan—breast cancer	0.299	0.5	CiPCiCtD
Thiotepa—Alkylating Activity—Chlorambucil—breast cancer	0.299	0.5	CiPCiCtD
Thiotepa—CYP3A4—breast cancer	0.104	1	CbGaD
Thiotepa—CYP2B6—Raloxifene—breast cancer	0.0233	0.125	CbGbCtD
Thiotepa—CYP3A4—Exemestane—breast cancer	0.0187	0.0999	CbGbCtD
Thiotepa—CYP3A4—Letrozole—breast cancer	0.0159	0.085	CbGbCtD
Thiotepa—CYP2B6—Tamoxifen—breast cancer	0.0154	0.0824	CbGbCtD
Thiotepa—CYP3A4—Anastrozole—breast cancer	0.0142	0.0757	CbGbCtD
Thiotepa—CYP3A4—Toremifene—breast cancer	0.013	0.0693	CbGbCtD
Thiotepa—CYP3A4—Fulvestrant—breast cancer	0.0121	0.0644	CbGbCtD
Thiotepa—CYP2B6—Irinotecan—breast cancer	0.0118	0.0633	CbGbCtD
Thiotepa—CYP3A4—Ixabepilone—breast cancer	0.00983	0.0525	CbGbCtD
Thiotepa—CYP3A4—Lapatinib—breast cancer	0.00946	0.0505	CbGbCtD
Thiotepa—CYP3A4—Raloxifene—breast cancer	0.00717	0.0383	CbGbCtD
Thiotepa—CYP2B6—Doxorubicin—breast cancer	0.00647	0.0346	CbGbCtD
Thiotepa—CYP3A4—Vinorelbine—breast cancer	0.00525	0.028	CbGbCtD
Thiotepa—CYP3A4—Tamoxifen—breast cancer	0.00474	0.0253	CbGbCtD
Thiotepa—CYP3A4—Mitoxantrone—breast cancer	0.00462	0.0247	CbGbCtD
Thiotepa—CYP3A4—Paclitaxel—breast cancer	0.00369	0.0197	CbGbCtD
Thiotepa—CYP3A4—Irinotecan—breast cancer	0.00364	0.0194	CbGbCtD
Thiotepa—CYP3A4—Vinblastine—breast cancer	0.00323	0.0173	CbGbCtD
Thiotepa—CYP3A4—Docetaxel—breast cancer	0.00267	0.0142	CbGbCtD
Thiotepa—CYP3A4—Doxorubicin—breast cancer	0.00199	0.0106	CbGbCtD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP19A1—breast cancer	2.09e-05	0.00278	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—breast cancer	2.07e-05	0.00275	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—breast cancer	2.04e-05	0.00272	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—breast cancer	2.03e-05	0.0027	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP17A1—breast cancer	2.02e-05	0.00269	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—PTGS1—breast cancer	2e-05	0.00266	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP17A1—breast cancer	1.99e-05	0.00265	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP2D6—breast cancer	1.96e-05	0.00261	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP2D6—breast cancer	1.94e-05	0.00257	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—NCOA2—breast cancer	1.93e-05	0.00256	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	1.8e-05	0.00239	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—breast cancer	1.77e-05	0.00236	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP3A4—breast cancer	1.73e-05	0.0023	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	1.73e-05	0.0023	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	1.71e-05	0.00228	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	1.71e-05	0.00228	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP3A4—breast cancer	1.71e-05	0.00227	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP1B1—breast cancer	1.7e-05	0.00226	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	1.69e-05	0.00225	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP1A1—breast cancer	1.68e-05	0.00224	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	1.68e-05	0.00223	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP1B1—breast cancer	1.68e-05	0.00223	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—breast cancer	1.67e-05	0.00222	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—ALDH1A1—breast cancer	1.65e-05	0.0022	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	1.65e-05	0.00219	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—NCOA1—breast cancer	1.62e-05	0.00216	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP19A1—breast cancer	1.6e-05	0.00213	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP19A1—breast cancer	1.58e-05	0.0021	CbGpPWpGaD
Thiotepa—Connective tissue disorder—Epirubicin—breast cancer	1.53e-05	0.000148	CcSEcCtD
Thiotepa—Abdominal pain—Paclitaxel—breast cancer	1.53e-05	0.000148	CcSEcCtD
Thiotepa—Body temperature increased—Paclitaxel—breast cancer	1.53e-05	0.000148	CcSEcCtD
Thiotepa—Urethral disorder—Epirubicin—breast cancer	1.53e-05	0.000148	CcSEcCtD
Thiotepa—Hepatobiliary disease—Doxorubicin—breast cancer	1.52e-05	0.000147	CcSEcCtD
Thiotepa—Epistaxis—Doxorubicin—breast cancer	1.51e-05	0.000146	CcSEcCtD
Thiotepa—Anorexia—Capecitabine—breast cancer	1.51e-05	0.000146	CcSEcCtD
Thiotepa—Angiopathy—Methotrexate—breast cancer	1.51e-05	0.000146	CcSEcCtD
Thiotepa—Vomiting—Mitoxantrone—breast cancer	1.51e-05	0.000146	CcSEcCtD
Thiotepa—Vomiting—Irinotecan—breast cancer	1.51e-05	0.000146	CcSEcCtD
Thiotepa—Immune system disorder—Methotrexate—breast cancer	1.5e-05	0.000145	CcSEcCtD
Thiotepa—Dizziness—Fluorouracil—breast cancer	1.5e-05	0.000145	CcSEcCtD
Thiotepa—Mediastinal disorder—Methotrexate—breast cancer	1.5e-05	0.000145	CcSEcCtD
Thiotepa—Agranulocytosis—Doxorubicin—breast cancer	1.5e-05	0.000145	CcSEcCtD
Thiotepa—Rash—Irinotecan—breast cancer	1.5e-05	0.000145	CcSEcCtD
Thiotepa—Rash—Mitoxantrone—breast cancer	1.5e-05	0.000145	CcSEcCtD
Thiotepa—Dermatitis—Irinotecan—breast cancer	1.49e-05	0.000145	CcSEcCtD
Thiotepa—Dermatitis—Mitoxantrone—breast cancer	1.49e-05	0.000145	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Docetaxel—breast cancer	1.49e-05	0.000144	CcSEcCtD
Thiotepa—Chills—Methotrexate—breast cancer	1.49e-05	0.000144	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—COMT—breast cancer	1.49e-05	0.00198	CbGpPWpGaD
Thiotepa—Headache—Mitoxantrone—breast cancer	1.49e-05	0.000144	CcSEcCtD
Thiotepa—Headache—Irinotecan—breast cancer	1.49e-05	0.000144	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—GSTP1—breast cancer	1.48e-05	0.00197	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTA3—breast cancer	1.47e-05	0.00196	CbGpPWpGaD
Thiotepa—Paraesthesia—Docetaxel—breast cancer	1.47e-05	0.000142	CcSEcCtD
Thiotepa—Alopecia—Methotrexate—breast cancer	1.47e-05	0.000142	CcSEcCtD
Thiotepa—Vomiting—Gemcitabine—breast cancer	1.47e-05	0.000142	CcSEcCtD
Thiotepa—CYP2B6—Metapathway biotransformation—COMT—breast cancer	1.47e-05	0.00195	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTP1—breast cancer	1.46e-05	0.00194	CbGpPWpGaD
Thiotepa—Somnolence—Docetaxel—breast cancer	1.46e-05	0.000141	CcSEcCtD
Thiotepa—Mental disorder—Methotrexate—breast cancer	1.46e-05	0.000141	CcSEcCtD
Thiotepa—Rash—Gemcitabine—breast cancer	1.46e-05	0.000141	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	1.46e-05	0.00194	CbGpPWpGaD
Thiotepa—Dermatitis—Gemcitabine—breast cancer	1.45e-05	0.000141	CcSEcCtD
Thiotepa—Eye disorder—Epirubicin—breast cancer	1.45e-05	0.000141	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTA3—breast cancer	1.45e-05	0.00193	CbGpPWpGaD
Thiotepa—Tinnitus—Epirubicin—breast cancer	1.45e-05	0.00014	CcSEcCtD
Thiotepa—Erythema—Methotrexate—breast cancer	1.45e-05	0.00014	CcSEcCtD
Thiotepa—Malnutrition—Methotrexate—breast cancer	1.45e-05	0.00014	CcSEcCtD
Thiotepa—Haemoglobin—Doxorubicin—breast cancer	1.45e-05	0.00014	CcSEcCtD
Thiotepa—Headache—Gemcitabine—breast cancer	1.45e-05	0.00014	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Capecitabine—breast cancer	1.45e-05	0.00014	CcSEcCtD
Thiotepa—Cardiac disorder—Epirubicin—breast cancer	1.44e-05	0.00014	CcSEcCtD
Thiotepa—Vomiting—Fluorouracil—breast cancer	1.44e-05	0.00014	CcSEcCtD
Thiotepa—Dyspepsia—Docetaxel—breast cancer	1.44e-05	0.00014	CcSEcCtD
Thiotepa—Haemorrhage—Doxorubicin—breast cancer	1.44e-05	0.000139	CcSEcCtD
Thiotepa—Rash—Fluorouracil—breast cancer	1.43e-05	0.000139	CcSEcCtD
Thiotepa—Dermatitis—Fluorouracil—breast cancer	1.43e-05	0.000138	CcSEcCtD
Thiotepa—Paraesthesia—Capecitabine—breast cancer	1.43e-05	0.000138	CcSEcCtD
Thiotepa—Decreased appetite—Docetaxel—breast cancer	1.42e-05	0.000138	CcSEcCtD
Thiotepa—Hypersensitivity—Paclitaxel—breast cancer	1.42e-05	0.000138	CcSEcCtD
Thiotepa—Headache—Fluorouracil—breast cancer	1.42e-05	0.000138	CcSEcCtD
Thiotepa—Urinary tract disorder—Doxorubicin—breast cancer	1.42e-05	0.000138	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Docetaxel—breast cancer	1.42e-05	0.000137	CcSEcCtD
Thiotepa—Connective tissue disorder—Doxorubicin—breast cancer	1.41e-05	0.000137	CcSEcCtD
Thiotepa—Fatigue—Docetaxel—breast cancer	1.41e-05	0.000137	CcSEcCtD
Thiotepa—Angiopathy—Epirubicin—breast cancer	1.41e-05	0.000137	CcSEcCtD
Thiotepa—Urethral disorder—Doxorubicin—breast cancer	1.41e-05	0.000137	CcSEcCtD
Thiotepa—Nausea—Mitoxantrone—breast cancer	1.41e-05	0.000136	CcSEcCtD
Thiotepa—Nausea—Irinotecan—breast cancer	1.41e-05	0.000136	CcSEcCtD
Thiotepa—Immune system disorder—Epirubicin—breast cancer	1.41e-05	0.000136	CcSEcCtD
Thiotepa—Mediastinal disorder—Epirubicin—breast cancer	1.4e-05	0.000136	CcSEcCtD
Thiotepa—Constipation—Docetaxel—breast cancer	1.4e-05	0.000136	CcSEcCtD
Thiotepa—Pain—Docetaxel—breast cancer	1.4e-05	0.000136	CcSEcCtD
Thiotepa—Back pain—Methotrexate—breast cancer	1.4e-05	0.000135	CcSEcCtD
Thiotepa—Dyspepsia—Capecitabine—breast cancer	1.4e-05	0.000135	CcSEcCtD
Thiotepa—Chills—Epirubicin—breast cancer	1.4e-05	0.000135	CcSEcCtD
Thiotepa—Arrhythmia—Epirubicin—breast cancer	1.39e-05	0.000135	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	1.39e-05	0.00185	CbGpPWpGaD
Thiotepa—Asthenia—Paclitaxel—breast cancer	1.39e-05	0.000134	CcSEcCtD
Thiotepa—Decreased appetite—Capecitabine—breast cancer	1.38e-05	0.000133	CcSEcCtD
Thiotepa—Alopecia—Epirubicin—breast cancer	1.38e-05	0.000133	CcSEcCtD
Thiotepa—Nausea—Gemcitabine—breast cancer	1.37e-05	0.000133	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Capecitabine—breast cancer	1.37e-05	0.000133	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	1.37e-05	0.00182	CbGpPWpGaD
Thiotepa—Fatigue—Capecitabine—breast cancer	1.37e-05	0.000132	CcSEcCtD
Thiotepa—Pruritus—Paclitaxel—breast cancer	1.37e-05	0.000132	CcSEcCtD
Thiotepa—Vision blurred—Methotrexate—breast cancer	1.36e-05	0.000132	CcSEcCtD
Thiotepa—Mental disorder—Epirubicin—breast cancer	1.36e-05	0.000132	CcSEcCtD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	1.36e-05	0.00181	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTM1—breast cancer	1.36e-05	0.00181	CbGpPWpGaD
Thiotepa—Pain—Capecitabine—breast cancer	1.36e-05	0.000131	CcSEcCtD
Thiotepa—Constipation—Capecitabine—breast cancer	1.36e-05	0.000131	CcSEcCtD
Thiotepa—Erythema—Epirubicin—breast cancer	1.35e-05	0.000131	CcSEcCtD
Thiotepa—Malnutrition—Epirubicin—breast cancer	1.35e-05	0.000131	CcSEcCtD
Thiotepa—Feeling abnormal—Docetaxel—breast cancer	1.35e-05	0.000131	CcSEcCtD
Thiotepa—Nausea—Fluorouracil—breast cancer	1.35e-05	0.000131	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—GSTA4—breast cancer	1.35e-05	0.00179	CbGpPWpGaD
Thiotepa—Eye disorder—Doxorubicin—breast cancer	1.35e-05	0.00013	CcSEcCtD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	1.34e-05	0.00179	CbGpPWpGaD
Thiotepa—Tinnitus—Doxorubicin—breast cancer	1.34e-05	0.00013	CcSEcCtD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTM1—breast cancer	1.34e-05	0.00178	CbGpPWpGaD
Thiotepa—Gastrointestinal pain—Docetaxel—breast cancer	1.34e-05	0.00013	CcSEcCtD
Thiotepa—Anaemia—Methotrexate—breast cancer	1.34e-05	0.000129	CcSEcCtD
Thiotepa—Cardiac disorder—Doxorubicin—breast cancer	1.34e-05	0.000129	CcSEcCtD
Thiotepa—Tension—Epirubicin—breast cancer	1.33e-05	0.000129	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	1.33e-05	0.00177	CbGpPWpGaD
Thiotepa—Diarrhoea—Paclitaxel—breast cancer	1.32e-05	0.000128	CcSEcCtD
Thiotepa—Nervousness—Epirubicin—breast cancer	1.32e-05	0.000127	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—GSTA2—breast cancer	1.31e-05	0.00175	CbGpPWpGaD
Thiotepa—Back pain—Epirubicin—breast cancer	1.31e-05	0.000127	CcSEcCtD
Thiotepa—Feeling abnormal—Capecitabine—breast cancer	1.31e-05	0.000127	CcSEcCtD
Thiotepa—Angiopathy—Doxorubicin—breast cancer	1.31e-05	0.000126	CcSEcCtD
Thiotepa—Immune system disorder—Doxorubicin—breast cancer	1.3e-05	0.000126	CcSEcCtD
Thiotepa—Gastrointestinal pain—Capecitabine—breast cancer	1.3e-05	0.000126	CcSEcCtD
Thiotepa—Mediastinal disorder—Doxorubicin—breast cancer	1.3e-05	0.000126	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—SULT1A1—breast cancer	1.3e-05	0.00172	CbGpPWpGaD
Thiotepa—Abdominal pain—Docetaxel—breast cancer	1.3e-05	0.000125	CcSEcCtD
Thiotepa—Body temperature increased—Docetaxel—breast cancer	1.3e-05	0.000125	CcSEcCtD
Thiotepa—Leukopenia—Methotrexate—breast cancer	1.3e-05	0.000125	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	1.29e-05	0.00172	CbGpPWpGaD
Thiotepa—Chills—Doxorubicin—breast cancer	1.29e-05	0.000125	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—CYP1A1—breast cancer	1.29e-05	0.00172	CbGpPWpGaD
Thiotepa—Arrhythmia—Doxorubicin—breast cancer	1.29e-05	0.000124	CcSEcCtD
Thiotepa—Dizziness—Paclitaxel—breast cancer	1.28e-05	0.000124	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	1.28e-05	0.0017	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	1.28e-05	0.0017	CbGpPWpGaD
Thiotepa—Vision blurred—Epirubicin—breast cancer	1.28e-05	0.000124	CcSEcCtD
Thiotepa—Alopecia—Doxorubicin—breast cancer	1.27e-05	0.000123	CcSEcCtD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP1A1—breast cancer	1.27e-05	0.00169	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTA1—breast cancer	1.27e-05	0.00168	CbGpPWpGaD
Thiotepa—Cough—Methotrexate—breast cancer	1.26e-05	0.000122	CcSEcCtD
Thiotepa—Mental disorder—Doxorubicin—breast cancer	1.26e-05	0.000122	CcSEcCtD
Thiotepa—Urticaria—Capecitabine—breast cancer	1.26e-05	0.000122	CcSEcCtD
Thiotepa—Abdominal pain—Capecitabine—breast cancer	1.25e-05	0.000121	CcSEcCtD
Thiotepa—Body temperature increased—Capecitabine—breast cancer	1.25e-05	0.000121	CcSEcCtD
Thiotepa—Convulsion—Methotrexate—breast cancer	1.25e-05	0.000121	CcSEcCtD
Thiotepa—Erythema—Doxorubicin—breast cancer	1.25e-05	0.000121	CcSEcCtD
Thiotepa—Malnutrition—Doxorubicin—breast cancer	1.25e-05	0.000121	CcSEcCtD
Thiotepa—Anaemia—Epirubicin—breast cancer	1.25e-05	0.000121	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—NAT2—breast cancer	1.25e-05	0.00166	CbGpPWpGaD
Thiotepa—Agitation—Epirubicin—breast cancer	1.24e-05	0.00012	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	1.23e-05	0.00164	CbGpPWpGaD
Thiotepa—Arthralgia—Methotrexate—breast cancer	1.23e-05	0.000119	CcSEcCtD
Thiotepa—Myalgia—Methotrexate—breast cancer	1.23e-05	0.000119	CcSEcCtD
Thiotepa—Tension—Doxorubicin—breast cancer	1.23e-05	0.000119	CcSEcCtD
Thiotepa—Vomiting—Paclitaxel—breast cancer	1.23e-05	0.000119	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.22e-05	0.000118	CcSEcCtD
Thiotepa—Rash—Paclitaxel—breast cancer	1.22e-05	0.000118	CcSEcCtD
Thiotepa—Dermatitis—Paclitaxel—breast cancer	1.22e-05	0.000118	CcSEcCtD
Thiotepa—Nervousness—Doxorubicin—breast cancer	1.22e-05	0.000118	CcSEcCtD
Thiotepa—Leukopenia—Epirubicin—breast cancer	1.21e-05	0.000117	CcSEcCtD
Thiotepa—Back pain—Doxorubicin—breast cancer	1.21e-05	0.000117	CcSEcCtD
Thiotepa—Headache—Paclitaxel—breast cancer	1.21e-05	0.000117	CcSEcCtD
Thiotepa—Hypersensitivity—Docetaxel—breast cancer	1.21e-05	0.000117	CcSEcCtD
Thiotepa—Confusional state—Methotrexate—breast cancer	1.19e-05	0.000115	CcSEcCtD
Thiotepa—Cough—Epirubicin—breast cancer	1.18e-05	0.000114	CcSEcCtD
Thiotepa—Vision blurred—Doxorubicin—breast cancer	1.18e-05	0.000114	CcSEcCtD
Thiotepa—Asthenia—Docetaxel—breast cancer	1.18e-05	0.000114	CcSEcCtD
Thiotepa—Convulsion—Epirubicin—breast cancer	1.17e-05	0.000114	CcSEcCtD
Thiotepa—Infection—Methotrexate—breast cancer	1.17e-05	0.000114	CcSEcCtD
Thiotepa—Hypertension—Epirubicin—breast cancer	1.17e-05	0.000113	CcSEcCtD
Thiotepa—Hypersensitivity—Capecitabine—breast cancer	1.17e-05	0.000113	CcSEcCtD
Thiotepa—Pruritus—Docetaxel—breast cancer	1.16e-05	0.000112	CcSEcCtD
Thiotepa—Nervous system disorder—Methotrexate—breast cancer	1.16e-05	0.000112	CcSEcCtD
Thiotepa—Anaemia—Doxorubicin—breast cancer	1.16e-05	0.000112	CcSEcCtD
Thiotepa—Thrombocytopenia—Methotrexate—breast cancer	1.16e-05	0.000112	CcSEcCtD
Thiotepa—Myalgia—Epirubicin—breast cancer	1.15e-05	0.000112	CcSEcCtD
Thiotepa—Arthralgia—Epirubicin—breast cancer	1.15e-05	0.000112	CcSEcCtD
Thiotepa—Agitation—Doxorubicin—breast cancer	1.15e-05	0.000111	CcSEcCtD
Thiotepa—Anxiety—Epirubicin—breast cancer	1.15e-05	0.000111	CcSEcCtD
Thiotepa—Nausea—Paclitaxel—breast cancer	1.15e-05	0.000111	CcSEcCtD
Thiotepa—Skin disorder—Methotrexate—breast cancer	1.15e-05	0.000111	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.15e-05	0.000111	CcSEcCtD
Thiotepa—Asthenia—Capecitabine—breast cancer	1.14e-05	0.00011	CcSEcCtD
Thiotepa—Anorexia—Methotrexate—breast cancer	1.13e-05	0.000109	CcSEcCtD
Thiotepa—Pruritus—Capecitabine—breast cancer	1.12e-05	0.000109	CcSEcCtD
Thiotepa—Leukopenia—Doxorubicin—breast cancer	1.12e-05	0.000109	CcSEcCtD
Thiotepa—Diarrhoea—Docetaxel—breast cancer	1.12e-05	0.000109	CcSEcCtD
Thiotepa—Confusional state—Epirubicin—breast cancer	1.11e-05	0.000108	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	1.1e-05	0.00147	CbGpPWpGaD
Thiotepa—Infection—Epirubicin—breast cancer	1.1e-05	0.000106	CcSEcCtD
Thiotepa—Cough—Doxorubicin—breast cancer	1.09e-05	0.000106	CcSEcCtD
Thiotepa—Convulsion—Doxorubicin—breast cancer	1.09e-05	0.000105	CcSEcCtD
Thiotepa—Diarrhoea—Capecitabine—breast cancer	1.09e-05	0.000105	CcSEcCtD
Thiotepa—Nervous system disorder—Epirubicin—breast cancer	1.08e-05	0.000105	CcSEcCtD
Thiotepa—Dizziness—Docetaxel—breast cancer	1.08e-05	0.000105	CcSEcCtD
Thiotepa—Thrombocytopenia—Epirubicin—breast cancer	1.08e-05	0.000105	CcSEcCtD
Thiotepa—Hypertension—Doxorubicin—breast cancer	1.08e-05	0.000105	CcSEcCtD
Thiotepa—Tachycardia—Epirubicin—breast cancer	1.08e-05	0.000104	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Methotrexate—breast cancer	1.08e-05	0.000104	CcSEcCtD
Thiotepa—Skin disorder—Epirubicin—breast cancer	1.07e-05	0.000104	CcSEcCtD
Thiotepa—Arthralgia—Doxorubicin—breast cancer	1.07e-05	0.000103	CcSEcCtD
Thiotepa—Myalgia—Doxorubicin—breast cancer	1.07e-05	0.000103	CcSEcCtD
Thiotepa—Anxiety—Doxorubicin—breast cancer	1.06e-05	0.000103	CcSEcCtD
Thiotepa—Paraesthesia—Methotrexate—breast cancer	1.06e-05	0.000103	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.06e-05	0.000103	CcSEcCtD
Thiotepa—Anorexia—Epirubicin—breast cancer	1.05e-05	0.000102	CcSEcCtD
Thiotepa—Somnolence—Methotrexate—breast cancer	1.05e-05	0.000102	CcSEcCtD
Thiotepa—Dizziness—Capecitabine—breast cancer	1.05e-05	0.000102	CcSEcCtD
Thiotepa—Vomiting—Docetaxel—breast cancer	1.04e-05	0.000101	CcSEcCtD
Thiotepa—Dyspepsia—Methotrexate—breast cancer	1.04e-05	0.000101	CcSEcCtD
Thiotepa—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	1.04e-05	0.00138	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SYNJ2—breast cancer	1.04e-05	0.00138	CbGpPWpGaD
Thiotepa—Rash—Docetaxel—breast cancer	1.03e-05	0.0001	CcSEcCtD
Thiotepa—Dermatitis—Docetaxel—breast cancer	1.03e-05	9.99e-05	CcSEcCtD
Thiotepa—Confusional state—Doxorubicin—breast cancer	1.03e-05	9.98e-05	CcSEcCtD
Thiotepa—Decreased appetite—Methotrexate—breast cancer	1.03e-05	9.94e-05	CcSEcCtD
Thiotepa—Headache—Docetaxel—breast cancer	1.03e-05	9.93e-05	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—MTR—breast cancer	1.02e-05	0.00136	CbGpPWpGaD
Thiotepa—Gastrointestinal disorder—Methotrexate—breast cancer	1.02e-05	9.87e-05	CcSEcCtD
Thiotepa—Fatigue—Methotrexate—breast cancer	1.02e-05	9.85e-05	CcSEcCtD
Thiotepa—Infection—Doxorubicin—breast cancer	1.02e-05	9.83e-05	CcSEcCtD
Thiotepa—Pain—Methotrexate—breast cancer	1.01e-05	9.77e-05	CcSEcCtD
Thiotepa—Vomiting—Capecitabine—breast cancer	1.01e-05	9.76e-05	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Epirubicin—breast cancer	1.01e-05	9.75e-05	CcSEcCtD
Thiotepa—Nervous system disorder—Doxorubicin—breast cancer	1e-05	9.71e-05	CcSEcCtD
Thiotepa—Thrombocytopenia—Doxorubicin—breast cancer	1e-05	9.69e-05	CcSEcCtD
Thiotepa—Rash—Capecitabine—breast cancer	1e-05	9.68e-05	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—HPGDS—breast cancer	1e-05	0.00133	CbGpPWpGaD
Thiotepa—Dermatitis—Capecitabine—breast cancer	1e-05	9.67e-05	CcSEcCtD
Thiotepa—Tachycardia—Doxorubicin—breast cancer	9.98e-06	9.66e-05	CcSEcCtD
Thiotepa—Headache—Capecitabine—breast cancer	9.94e-06	9.62e-05	CcSEcCtD
Thiotepa—Skin disorder—Doxorubicin—breast cancer	9.94e-06	9.61e-05	CcSEcCtD
Thiotepa—Paraesthesia—Epirubicin—breast cancer	9.93e-06	9.61e-05	CcSEcCtD
Thiotepa—Somnolence—Epirubicin—breast cancer	9.83e-06	9.51e-05	CcSEcCtD
Thiotepa—Anorexia—Doxorubicin—breast cancer	9.75e-06	9.43e-05	CcSEcCtD
Thiotepa—Nausea—Docetaxel—breast cancer	9.74e-06	9.42e-05	CcSEcCtD
Thiotepa—Feeling abnormal—Methotrexate—breast cancer	9.74e-06	9.42e-05	CcSEcCtD
Thiotepa—Dyspepsia—Epirubicin—breast cancer	9.73e-06	9.42e-05	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—GSTT1—breast cancer	9.71e-06	0.00129	CbGpPWpGaD
Thiotepa—Gastrointestinal pain—Methotrexate—breast cancer	9.66e-06	9.35e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—NDUFS3—breast cancer	9.65e-06	0.00128	CbGpPWpGaD
Thiotepa—Decreased appetite—Epirubicin—breast cancer	9.61e-06	9.3e-05	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Epirubicin—breast cancer	9.54e-06	9.23e-05	CcSEcCtD
Thiotepa—Fatigue—Epirubicin—breast cancer	9.53e-06	9.22e-05	CcSEcCtD
Thiotepa—Pain—Epirubicin—breast cancer	9.45e-06	9.15e-05	CcSEcCtD
Thiotepa—Constipation—Epirubicin—breast cancer	9.45e-06	9.15e-05	CcSEcCtD
Thiotepa—Nausea—Capecitabine—breast cancer	9.43e-06	9.12e-05	CcSEcCtD
Thiotepa—Urticaria—Methotrexate—breast cancer	9.39e-06	9.08e-05	CcSEcCtD
Thiotepa—Body temperature increased—Methotrexate—breast cancer	9.34e-06	9.04e-05	CcSEcCtD
Thiotepa—Abdominal pain—Methotrexate—breast cancer	9.34e-06	9.04e-05	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Doxorubicin—breast cancer	9.32e-06	9.02e-05	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP17A1—breast cancer	9.19e-06	0.00122	CbGpPWpGaD
Thiotepa—Paraesthesia—Doxorubicin—breast cancer	9.19e-06	8.89e-05	CcSEcCtD
Thiotepa—Feeling abnormal—Epirubicin—breast cancer	9.11e-06	8.81e-05	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—PTGS1—breast cancer	9.09e-06	0.00121	CbGpPWpGaD
Thiotepa—Somnolence—Doxorubicin—breast cancer	9.09e-06	8.8e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—CHST9—breast cancer	9.07e-06	0.00121	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	9.06e-06	0.00121	CbGpPWpGaD
Thiotepa—Gastrointestinal pain—Epirubicin—breast cancer	9.04e-06	8.75e-05	CcSEcCtD
Thiotepa—Dyspepsia—Doxorubicin—breast cancer	9e-06	8.71e-05	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP2D6—breast cancer	8.92e-06	0.00119	CbGpPWpGaD
Thiotepa—Decreased appetite—Doxorubicin—breast cancer	8.89e-06	8.6e-05	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Doxorubicin—breast cancer	8.83e-06	8.54e-05	CcSEcCtD
Thiotepa—Fatigue—Doxorubicin—breast cancer	8.82e-06	8.53e-05	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	8.8e-06	0.00117	CbGpPWpGaD
Thiotepa—Urticaria—Epirubicin—breast cancer	8.78e-06	8.5e-05	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—NCOA2—breast cancer	8.75e-06	0.00116	CbGpPWpGaD
Thiotepa—Pain—Doxorubicin—breast cancer	8.75e-06	8.46e-05	CcSEcCtD
Thiotepa—Constipation—Doxorubicin—breast cancer	8.75e-06	8.46e-05	CcSEcCtD
Thiotepa—Abdominal pain—Epirubicin—breast cancer	8.74e-06	8.46e-05	CcSEcCtD
Thiotepa—Body temperature increased—Epirubicin—breast cancer	8.74e-06	8.46e-05	CcSEcCtD
Thiotepa—Hypersensitivity—Methotrexate—breast cancer	8.7e-06	8.42e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—COX11—breast cancer	8.6e-06	0.00114	CbGpPWpGaD
Thiotepa—Asthenia—Methotrexate—breast cancer	8.48e-06	8.2e-05	CcSEcCtD
Thiotepa—Feeling abnormal—Doxorubicin—breast cancer	8.43e-06	8.16e-05	CcSEcCtD
Thiotepa—Gastrointestinal pain—Doxorubicin—breast cancer	8.37e-06	8.09e-05	CcSEcCtD
Thiotepa—Pruritus—Methotrexate—breast cancer	8.36e-06	8.09e-05	CcSEcCtD
Thiotepa—Hypersensitivity—Epirubicin—breast cancer	8.15e-06	7.88e-05	CcSEcCtD
Thiotepa—Urticaria—Doxorubicin—breast cancer	8.13e-06	7.86e-05	CcSEcCtD
Thiotepa—Abdominal pain—Doxorubicin—breast cancer	8.09e-06	7.82e-05	CcSEcCtD
Thiotepa—Body temperature increased—Doxorubicin—breast cancer	8.09e-06	7.82e-05	CcSEcCtD
Thiotepa—Diarrhoea—Methotrexate—breast cancer	8.08e-06	7.82e-05	CcSEcCtD
Thiotepa—Asthenia—Epirubicin—breast cancer	7.93e-06	7.67e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—CDA—breast cancer	7.86e-06	0.00105	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SHMT1—breast cancer	7.86e-06	0.00105	CbGpPWpGaD
Thiotepa—Pruritus—Epirubicin—breast cancer	7.82e-06	7.57e-05	CcSEcCtD
Thiotepa—Dizziness—Methotrexate—breast cancer	7.81e-06	7.56e-05	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—CYP1B1—breast cancer	7.73e-06	0.00103	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	7.63e-06	0.00101	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLCO1B1—breast cancer	7.57e-06	0.00101	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC2A5—breast cancer	7.57e-06	0.00101	CbGpPWpGaD
Thiotepa—Diarrhoea—Epirubicin—breast cancer	7.56e-06	7.32e-05	CcSEcCtD
Thiotepa—Hypersensitivity—Doxorubicin—breast cancer	7.54e-06	7.29e-05	CcSEcCtD
Thiotepa—Vomiting—Methotrexate—breast cancer	7.51e-06	7.27e-05	CcSEcCtD
Thiotepa—Rash—Methotrexate—breast cancer	7.45e-06	7.21e-05	CcSEcCtD
Thiotepa—Dermatitis—Methotrexate—breast cancer	7.44e-06	7.2e-05	CcSEcCtD
Thiotepa—Headache—Methotrexate—breast cancer	7.4e-06	7.16e-05	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—NCOA1—breast cancer	7.38e-06	0.000981	CbGpPWpGaD
Thiotepa—Asthenia—Doxorubicin—breast cancer	7.34e-06	7.1e-05	CcSEcCtD
Thiotepa—Dizziness—Epirubicin—breast cancer	7.31e-06	7.07e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—APRT—breast cancer	7.31e-06	0.000972	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP19A1—breast cancer	7.27e-06	0.000967	CbGpPWpGaD
Thiotepa—Pruritus—Doxorubicin—breast cancer	7.24e-06	7e-05	CcSEcCtD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	7.17e-06	0.000954	CbGpPWpGaD
Thiotepa—Vomiting—Epirubicin—breast cancer	7.03e-06	6.8e-05	CcSEcCtD
Thiotepa—Nausea—Methotrexate—breast cancer	7.02e-06	6.79e-05	CcSEcCtD
Thiotepa—Diarrhoea—Doxorubicin—breast cancer	7e-06	6.77e-05	CcSEcCtD
Thiotepa—Rash—Epirubicin—breast cancer	6.97e-06	6.74e-05	CcSEcCtD
Thiotepa—Dermatitis—Epirubicin—breast cancer	6.96e-06	6.74e-05	CcSEcCtD
Thiotepa—Headache—Epirubicin—breast cancer	6.93e-06	6.7e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—ESRRA—breast cancer	6.87e-06	0.000914	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ANGPTL4—breast cancer	6.87e-06	0.000914	CbGpPWpGaD
Thiotepa—Dizziness—Doxorubicin—breast cancer	6.76e-06	6.54e-05	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—COMT—breast cancer	6.76e-06	0.000899	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTP1—breast cancer	6.73e-06	0.000895	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—COMT—breast cancer	6.67e-06	0.000887	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	6.63e-06	0.000883	CbGpPWpGaD
Thiotepa—Nausea—Epirubicin—breast cancer	6.57e-06	6.35e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—GPI—breast cancer	6.52e-06	0.000867	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HADHB—breast cancer	6.52e-06	0.000867	CbGpPWpGaD
Thiotepa—Vomiting—Doxorubicin—breast cancer	6.5e-06	6.29e-05	CcSEcCtD
Thiotepa—Rash—Doxorubicin—breast cancer	6.45e-06	6.24e-05	CcSEcCtD
Thiotepa—Dermatitis—Doxorubicin—breast cancer	6.44e-06	6.23e-05	CcSEcCtD
Thiotepa—Headache—Doxorubicin—breast cancer	6.41e-06	6.2e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—ALDH7A1—breast cancer	6.22e-06	0.000827	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALDH1A1—breast cancer	6.22e-06	0.000827	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTM1—breast cancer	6.18e-06	0.000822	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	6.1e-06	0.000811	CbGpPWpGaD
Thiotepa—Nausea—Doxorubicin—breast cancer	6.08e-06	5.88e-05	CcSEcCtD
Thiotepa—CYP2B6—Metabolism—PHGDH—breast cancer	5.96e-06	0.000793	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—UMPS—breast cancer	5.96e-06	0.000793	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ADSL—breast cancer	5.96e-06	0.000793	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—FHL2—breast cancer	5.96e-06	0.000793	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NME1—breast cancer	5.96e-06	0.000793	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP1A1—breast cancer	5.86e-06	0.00078	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—LDHB—breast cancer	5.84e-06	0.000777	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HPSE—breast cancer	5.84e-06	0.000777	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—BRIP1—breast cancer	5.84e-06	0.000777	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	5.78e-06	0.000769	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ABCC1—breast cancer	5.54e-06	0.000737	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA3—breast cancer	5.54e-06	0.000737	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HMMR—breast cancer	5.54e-06	0.000737	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PPARGC1B—breast cancer	5.37e-06	0.000714	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA4—breast cancer	5.07e-06	0.000674	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CA9—breast cancer	5.07e-06	0.000674	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GPX2—breast cancer	4.94e-06	0.000657	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA2—breast cancer	4.94e-06	0.000657	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GPX4—breast cancer	4.88e-06	0.000649	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SULT1A1—breast cancer	4.88e-06	0.000649	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA1—breast cancer	4.76e-06	0.000634	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—IDH1—breast cancer	4.76e-06	0.000634	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SYNJ2—breast cancer	4.71e-06	0.000627	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NAT2—breast cancer	4.71e-06	0.000627	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NDUFS3—breast cancer	4.38e-06	0.000583	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MED12—breast cancer	4.13e-06	0.000549	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—DPYD—breast cancer	4.13e-06	0.000549	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CHST9—breast cancer	4.12e-06	0.000548	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALDOA—breast cancer	4.07e-06	0.000541	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NCOA3—breast cancer	3.95e-06	0.000525	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC2A2—breast cancer	3.92e-06	0.000521	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—COX11—breast cancer	3.91e-06	0.00052	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CPT1A—breast cancer	3.84e-06	0.000511	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MTR—breast cancer	3.84e-06	0.000511	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ABCG2—breast cancer	3.84e-06	0.000511	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HPGDS—breast cancer	3.77e-06	0.000501	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HBA1—breast cancer	3.74e-06	0.000498	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ACHE—breast cancer	3.65e-06	0.000486	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTT1—breast cancer	3.65e-06	0.000486	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CDA—breast cancer	3.57e-06	0.000475	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SHMT1—breast cancer	3.57e-06	0.000475	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP17A1—breast cancer	3.46e-06	0.00046	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLCO1B1—breast cancer	3.44e-06	0.000458	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC2A5—breast cancer	3.44e-06	0.000458	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PTGS1—breast cancer	3.42e-06	0.000455	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ENO1—breast cancer	3.42e-06	0.000455	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP2D6—breast cancer	3.36e-06	0.000446	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—APRT—breast cancer	3.32e-06	0.000442	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NCOA2—breast cancer	3.29e-06	0.000438	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—FASN—breast cancer	3.2e-06	0.000425	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—BCHE—breast cancer	3.18e-06	0.000423	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC5A5—breast cancer	3.14e-06	0.000418	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ESRRA—breast cancer	3.12e-06	0.000415	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ANGPTL4—breast cancer	3.12e-06	0.000415	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC2A1—breast cancer	3.04e-06	0.000404	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NQO1—breast cancer	3.04e-06	0.000404	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HADHB—breast cancer	2.96e-06	0.000394	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GPI—breast cancer	2.96e-06	0.000394	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP3A4—breast cancer	2.96e-06	0.000394	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP1B1—breast cancer	2.91e-06	0.000387	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HSP90AA1—breast cancer	2.85e-06	0.00038	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALDH7A1—breast cancer	2.82e-06	0.000376	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALDH1A1—breast cancer	2.82e-06	0.000376	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NCOA1—breast cancer	2.78e-06	0.000369	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—STK11—breast cancer	2.74e-06	0.000364	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP19A1—breast cancer	2.74e-06	0.000364	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PHGDH—breast cancer	2.71e-06	0.00036	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ADSL—breast cancer	2.71e-06	0.00036	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—UMPS—breast cancer	2.71e-06	0.00036	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NME1—breast cancer	2.71e-06	0.00036	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—FHL2—breast cancer	2.71e-06	0.00036	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HPSE—breast cancer	2.66e-06	0.000353	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—BRIP1—breast cancer	2.66e-06	0.000353	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—LDHB—breast cancer	2.66e-06	0.000353	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—COMT—breast cancer	2.54e-06	0.000338	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTP1—breast cancer	2.53e-06	0.000337	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ABCC1—breast cancer	2.52e-06	0.000335	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HMMR—breast cancer	2.52e-06	0.000335	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA3—breast cancer	2.52e-06	0.000335	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HMOX1—breast cancer	2.5e-06	0.000332	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ITPR1—breast cancer	2.49e-06	0.000331	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PPARGC1B—breast cancer	2.44e-06	0.000324	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ABCB1—breast cancer	2.4e-06	0.000319	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—TYMS—breast cancer	2.35e-06	0.000313	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PLA2G4A—breast cancer	2.33e-06	0.000309	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTM1—breast cancer	2.33e-06	0.000309	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NCOR1—breast cancer	2.33e-06	0.000309	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CA9—breast cancer	2.3e-06	0.000306	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA4—breast cancer	2.3e-06	0.000306	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA2—breast cancer	2.24e-06	0.000298	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GPX2—breast cancer	2.24e-06	0.000298	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GPX1—breast cancer	2.23e-06	0.000296	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SULT1A1—breast cancer	2.22e-06	0.000295	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GPX4—breast cancer	2.22e-06	0.000295	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP1A1—breast cancer	2.21e-06	0.000293	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ERCC2—breast cancer	2.19e-06	0.000291	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—IDH1—breast cancer	2.16e-06	0.000288	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA1—breast cancer	2.16e-06	0.000288	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NAT2—breast cancer	2.14e-06	0.000285	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MTHFR—breast cancer	2.06e-06	0.000274	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CAV1—breast cancer	1.9e-06	0.000252	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—DPYD—breast cancer	1.88e-06	0.00025	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MED12—breast cancer	1.88e-06	0.00025	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALDOA—breast cancer	1.85e-06	0.000246	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NCOA3—breast cancer	1.79e-06	0.000239	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC2A2—breast cancer	1.78e-06	0.000237	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ABCG2—breast cancer	1.74e-06	0.000232	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CPT1A—breast cancer	1.74e-06	0.000232	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MTR—breast cancer	1.74e-06	0.000232	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CG—breast cancer	1.73e-06	0.00023	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HPGDS—breast cancer	1.71e-06	0.000228	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HBA1—breast cancer	1.7e-06	0.000226	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTT1—breast cancer	1.66e-06	0.000221	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ACHE—breast cancer	1.66e-06	0.000221	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP17A1—breast cancer	1.57e-06	0.000209	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ENO1—breast cancer	1.56e-06	0.000207	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PTGS1—breast cancer	1.56e-06	0.000207	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2D6—breast cancer	1.53e-06	0.000203	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CD—breast cancer	1.52e-06	0.000202	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALB—breast cancer	1.5e-06	0.000199	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NCOA2—breast cancer	1.5e-06	0.000199	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—FASN—breast cancer	1.45e-06	0.000193	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—BCHE—breast cancer	1.45e-06	0.000192	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NOS3—breast cancer	1.43e-06	0.000191	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC5A5—breast cancer	1.43e-06	0.00019	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC2A1—breast cancer	1.38e-06	0.000183	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NQO1—breast cancer	1.38e-06	0.000183	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CB—breast cancer	1.32e-06	0.000176	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP1B1—breast cancer	1.32e-06	0.000176	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PTGS2—breast cancer	1.31e-06	0.000174	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.3e-06	0.000173	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NCOA1—breast cancer	1.26e-06	0.000168	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP19A1—breast cancer	1.24e-06	0.000165	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—STK11—breast cancer	1.24e-06	0.000165	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—COMT—breast cancer	1.16e-06	0.000154	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTP1—breast cancer	1.15e-06	0.000153	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PTEN—breast cancer	1.14e-06	0.000152	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HMOX1—breast cancer	1.13e-06	0.000151	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ITPR1—breast cancer	1.13e-06	0.000151	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ABCB1—breast cancer	1.09e-06	0.000145	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—TYMS—breast cancer	1.07e-06	0.000142	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTM1—breast cancer	1.06e-06	0.000141	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NCOR1—breast cancer	1.06e-06	0.000141	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.06e-06	0.000141	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GPX1—breast cancer	1.01e-06	0.000135	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP1A1—breast cancer	1e-06	0.000133	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ERCC2—breast cancer	9.94e-07	0.000132	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MTHFR—breast cancer	9.34e-07	0.000124	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CAV1—breast cancer	8.62e-07	0.000115	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CA—breast cancer	8.07e-07	0.000107	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CG—breast cancer	7.85e-07	0.000104	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CD—breast cancer	6.9e-07	9.18e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALB—breast cancer	6.81e-07	9.06e-05	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—AKT1—breast cancer	6.59e-07	8.77e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NOS3—breast cancer	6.52e-07	8.67e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CB—breast cancer	6.01e-07	8e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PTGS2—breast cancer	5.96e-07	7.93e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PTEN—breast cancer	5.2e-07	6.91e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CA—breast cancer	3.67e-07	4.88e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AKT1—breast cancer	3e-07	3.98e-05	CbGpPWpGaD
